Retatrutide (pronounced reh-TAT-tru-tide) is a synthetic peptide-based therapy that activates three key hormone receptors involved in metabolism: GLP-1 receptor (Glucagon-Like Peptide-1) GIP receptor (Glucose-Dependent Insulinotropic Polypeptide) Glucagon receptor This makes Retatrutide a triple agonist a unique advancement over medications like semaglutide (Wegovy/Ozempic) and tirzepatide (Mounjaro/Zepbound) , which activate only one or two of these receptors
At Curely, we believe everyone deserves easy, affordable access to the medications they need, regardless of their circumstances
Fang X, Han H, Li M, et al
Interestingly, as discussed in more detail below, some surprising new discoveries are showing that the body may already hold a secret in combating illness-like behaviors with a GI-derived hormone, gastric inhibitory peptide (GIP), that is rapidly secreted during the early phases of meal consumption
Recovery from psychotic illness: a 15- and 25-year international follow-up study
